Go Back

NEPHROCARE HEALTH SERVICES PRIVATE LIMITED

NephroPlus

U85100TG2009PTC066359

Get Comprehensive Report

₹1,999.00 ₹3,998.00
Suggest Edit Last updated: Jan 24, 2025
Key Metrics
  • No. of Employees898
  • Founded Year 2009
  • Company StagePrivate Limited Company
  • Total Funding₹1,636.69 Cr
  • Industry

  • Headquarter
  • Company StatusActive
About NephroPlus

NephroPlus, a provider network of dialysis services, entered the Indian dialysis market in 2009 with the goal of transforming the entire industry. The company provides the complete range of healthcare services that kidney failure patients need to lead productive lives, including hemodialysis, peritoneal dialysis, and kidney transplant services. To deliver these services NephroPlus designs, builds, and operates low-cost centers that provide high quality and affordable dialysis services. Centers are established through partnerships with hospitals or as standalone facilities.

Business Model

Healthcare platform NephroPlus is a dialysis center network that operates over 275 dialysis centers in more than 170 cities in India and treats nearly 20k patients on a monthly basis. In the past few years it added 80-plus centers in India, entered the Philippines market with acquisition of Royal Care Dialysis

Top Competitors
VI
VituscareU24290HR2017PTC069927
7I
7med IndiaU51101DL2013PTC261898
DK
Dcdc Kidney CareU85190DL2014PTC265804
NephroPlus Funding Details
Funding Highlights
Latest Funding RoundSeries F
Total Funding Raised₹1,636.69 Cr
No. of Investments Made0
Total No. of Acquisitions2
Lead Investors4
Investors
  • IFC, Besemer Venture Partners, Investcorp, IIFL Asset Management
Note:

Valuation as on Dec 13, 2021

Funding Details
TheKredible's detailed funding report contains info about Funding raised by the company along with Lead Investors, Investors, Shareholding Strcuture, and its Investments & Acquisitions.
₹799.00 ₹1,598.00
Funding History
TheKredible's 'Funding History' report provides deep insights of Funding with list of Lead Investors
₹399.00 ₹798.00
Funding Per Year
A Funding report of the company's overall funding on yearly basis, segregated by the team TheKredible.
₹199.00 ₹398.00
Acquisition Company Done
Detailed report about the Acquistions the company has done till date.
₹499.00 ₹998.00
NephroPlus Financial Details
Financial Highlights
FY 2023-24 Revenue₹574.72 Cr
FY 2023-24 Expenses₹541.56 Cr
FY 2023-24 Profit/Loss₹35.13 Cr
Net Cash Flow From Operations₹60.63 Cr
Full Financial Details
Detailed report containing info about Business Model, year-wise Financial Comparison, Ratio Analysis and detailed Revenue and Expense breakdowns.
₹799.00 ₹1,598.00
Financial Comparison
A detailed report of year-wise Financial Comparison of the company
₹430.00 ₹860.00
Revenue Breakdown
A report and breakdown of the company's year-wise revenue streams.
₹399.00 ₹798.00
Expense Breakdown
A report and breakdown of the company's year-wise expenditures.
₹399.00 ₹798.00
Shareholding Structure
Team at TheKredible has gone through several ROC filings and portrayed Shareholding Structure of the company.
₹499.00 ₹998.00
Financial Ratio
Analysis of Financial Ratios which gives quick insights about the company's profitability and capital efficiency.
₹199.00 ₹398.00
NephroPlus Key People
People Metrics
Current Core Team2
Board Members/Directors8

Core Team

VV
Vikram VuppalaCo-Founder & CEO
KS
Kamal Shah Co-Founder

Board Members/Directors

VV
Vikram VuppalaManaging Director
HS
Hemant SultaniaDirector
OP
Om Prakash ManchandaDirector
VA
Vasuta AgarwalDirector
VV
Vishal Vijay GuptaDirector
NG
Nidhi GhumanNominee Director
TG
Tiruvarur Gopalakrishnan Raja KarthikNominee Director
GS
Gaurav SharmaNominee Director
NephroPlus Documents

AY - 2018-19

Profit and Loss statement - NephroPlus - 2018-19.pdf
TheKredible's experts has summarized the Profit and Loss Statement of NephroPlus for FY 2018-19.
₹249.00 ₹498.00
Balance Sheet - NephroPlus - 2018-19.pdf
TheKredible's experts has summarized the Balance Sheet of NephroPlus for FY 2018-19.
₹249.00 ₹498.00

AY - 2019-20

Profit and Loss statement - NephroPlus - 2019-20.pdf
TheKredible's experts has summarized the Profit and Loss Statement of NephroPlus for FY 2019-20.
₹249.00 ₹498.00
Balance Sheet - NephroPlus - 2019-20.pdf
TheKredible's experts has summarized the Balance Sheet of NephroPlus for FY 2019-20.
₹249.00 ₹498.00

AY - 2020-21

Profit and Loss statement - NephroPlus - 2020-21.pdf
TheKredible's experts has summarized the Profit and Loss Statement of NephroPlus for FY 2020-21.
₹249.00 ₹498.00
Balance Sheet - NephroPlus - 2020-21.pdf
TheKredible's experts has summarized the Balance Sheet of NephroPlus for FY 2020-21.
₹249.00 ₹498.00

AY - 2021-22

Profit and Loss statement - NephroPlus - 2021-22.pdf
TheKredible's experts has summarized the Profit and Loss Statement of NephroPlus for FY 2021-22.
₹249.00 ₹498.00
Balance Sheet - NephroPlus - 2021-22.pdf
TheKredible's experts has summarized the Balance Sheet of NephroPlus for FY 2021-22.
₹249.00 ₹498.00

AY - 2022-23

Profit and loss statement - NephroPlus - 2022-23.pdf
TheKredible's experts has summarized the Profit and Loss Statement of NephroPlus for FY 2022-23
₹249.00 ₹498.00
Balance sheet - NephroPlus - 2022-23.pdf
TheKredible's experts has summarized the Balance Sheet of NephroPlus for FY 2022-23
₹249.00 ₹498.00

AY - 2023-24

Profit and loss statement - NephroPlus - 2023-24.pdf
TheKredible's experts has summarized the Profit and Loss Statement of NephroPlus for FY 2023-24
₹249.00 ₹498.00
Balance sheet - NephroPlus - 2023-24.pdf
TheKredible's experts has summarized the Balance Sheet of NephroPlus for FY 2023-24
₹249.00 ₹498.00

Subscribe to our newsletter to stay updated

Weekly Funding Reports
Funding Report
Weekly Funding Report [14 Apr - 19 Apr, 2025]
Monthly Funding Reports
Funding Report
Indian startup funding declines over 50% in Februa...

Get your Customised Report

With an exclusive 20% off on your order

Latest Industry Reports
Industry Report
HealthTech’s Rebound: After a Downturn, HealthTech...